论文部分内容阅读
目的探讨米非司酮联合丹鳖胶囊治疗子宫肌瘤的临床效果。方法选取的研究对象是2011年~2013年在我院接受治疗的129例子宫肌瘤患者,将患者随机分成两组,单独采用米非司酮治疗64例作国对照组患者,同时使用米非司酮和丹鳖胶囊治疗65例作为观察组患者,对比两种治疗方法的不同疗效。结果对照组治疗前的肿瘤体积是(4.8±1.9)cm3,治疗后的肿瘤体积是(2.2±1.3)cm3。观察组治疗前的肿瘤体积是(4.9±1.6)cm3,治疗后的肿瘤体积是(1.6±1.2)cm3。观察组的肿瘤体积减少程度显然优于对照组。接受治疗后,子宫肌瘤患者的孕酮、LH、雌二醇、FSH均有所下降,观察组的性激素下降幅度显然高于对照组。结论同时使用米非司酮联合丹鳖胶囊治疗子宫肌瘤的疗效明显。
Objective To investigate the clinical efficacy of mifepristone combined with Dan-tu capsule in the treatment of uterine fibroids. Methods The selected subjects were 129 patients with uterine fibroids who were treated in our hospital from 2011 to 2013. The patients were randomly divided into two groups. 64 patients treated with mifepristone alone were treated with Mifepristone Acetone and Dan-tu capsule treatment of 65 cases as the observation group of patients, compared the two different treatment efficacy. Results The volume of tumor before treatment in control group was (4.8 ± 1.9) cm3, and the volume of tumor after treatment was (2.2 ± 1.3) cm3. The volume of tumor in observation group before treatment was (4.9 ± 1.6) cm3, and the volume of tumor after treatment was (1.6 ± 1.2) cm3. Observation group tumor volume reduction is clearly better than the control group. After treatment, uterine fibroids in patients with progesterone, LH, estradiol, FSH decreased, the observation group, the decline in sex hormones was significantly higher than the control group. Conclusions Simultaneous use of mifepristone combined with Dan-tu capsule in the treatment of uterine fibroids obvious effect.